The European Commission granted approval for AbbVie‘s all-pill hepatitis C treatment for use in the 28 European Union countries, according to an abc News report.
Michael Phalen, executive vice president with Boston Scientific, sold 10,000 shares of company stock for a total transaction value of $145,400, according to a WKRB News & Analysis report.
Non-profit association Georgia Bio granted EndoChoice one of its Innovation Awards for the Fuse Full Spectrum Endoscopy System.
India’s patent office rejected Gilead Science‘s key patent claim for its hepatitis C drug Sovaldi. Gilead Sciences has the option to appeal the rejection.
Medigus extended its 2013 exclusive distribution agreement with Chinese pharmaceutical company Sinopharm. The agreement grants Sinopharm exclusive rights to distribute the MUSE system in China.
Salix Pharmaceuticals is working with investment bank Centerview Partners Holdings to explore options, such as a potential sale, according to a Reuters report.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
FDA approves pacemaker-like device to treat obesity
Northfield Hospital & Clinics to open $6.3M endoscopy center
Dr. Khaled Elraie joins Nanticoke Physician Network
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
